The Allegra transcatheter heart valve: European multicentre experience with a novel self-expanding transcatheter aortic valve.
暂无分享，去创建一个
M. Taramasso | F. Nietlispach | R. Moreno | S. Toggweiler | J. Baz | V. Jiménez | M. Brinkert | J. Sánchez-Gila | Virginia Pascual-Tejerina | E. Molina | Oscar Cuevas
[1] Helmut Baumgartner,et al. [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. , 2017, Kardiologia polska.
[2] P. Wenaweser,et al. Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[3] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[4] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[5] Pascal Vranckx,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.